Summary:
The purpose of the study is to determine the safety and tolerability of an investigational medication being developed for the treatment of psoriasis. The study drug or placebo will be given as a cream directly on the skin.
Qualified Participants Must:
• Be 18-65 years of age
•
Be diagnosed with psoriasis for at least 6 months
•
Have a body mass index less than 40
Qualified Participants May Receive:
Study related vital signs, ECGs, physical examinations, labs and may be compensated up to $4175.00 for time and travel.